Fingerprint
Dive into the research topics of 'Optimal Use of FOLFOXIRI Plus Bevacizumab as First-Line Systemic Treatment in Metastatic Colorectal Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Optimal Use of FOLFOXIRI Plus Bevacizumab as First-Line Systemic Treatment in Metastatic Colorectal Cancer
Jude Khatib, Radhika Kainthla
Research output: Contribution to journal › Review article › peer-review
1
Scopus
citations